This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB02290/identifier/pubchem-compound/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB02290/identifier/pubchem-substance/
n6http://linked.opendata.cz/resource/drugbank/drug/DB02290/identifier/drugbank/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB02290/identifier/pdb/

Statements

Subject Item
n2:DB02290
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB02290 n13:DB02290
dcterms:title
3-{2,6,8-Trioxo-9-[(2s,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate
adms:identifier
n6:DB02290 n9:46508558 n10:T5P n11:657024
n3:IUPAC-Name
n4:271B4F85-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4F8B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4F8A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4F87-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4F88-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4F89-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4F83-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4F81-363D-11E5-9242-09173F13E4C5 n4:271B4F84-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4F82-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4F91-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4F92-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4F8C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4F8D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4F8F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4F8E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4F90-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4F97-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4F99-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4F9A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4F96-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4F95-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4F98-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4F86-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4F93-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4F94-363D-11E5-9242-09173F13E4C5